UGRP2 Inhibitors
Chemical inhibitors of UGRP2 can interact with and modulate the activity of this protein through various biochemical pathways. Genistein's approach to inhibiting UGRP2 is through the modulation of protein tyrosine kinases, which are crucial in the signaling pathways that control UGRP2 activity relating to cellular differentiation and the immune system's response.
The second set of chemical inhibitors, including Quercetin and Ebselen, can inhibit UGRP2 by different mechanisms. Quercetin's antioxidant properties and its ability to regulate signalling pathways such as PI3K/Akt, which are implicated in UGRP2 regulation, contribute to its inhibitory effect. Ebselen mimics glutathione peroxidase activity, which reduces oxidative stress and modulates redox-sensitive pathways controlling UGRP2 expression during airway inflammation and immune responses. Indomethacin suppresses UGRP2 by inhibiting cyclooxygenase enzymes, thus indirectly affecting UGRP2 activity associated with pro-inflammatory signalling. N-acetylcysteine, through its support as an antioxidant, can modulate the redox state and oxidative stress-related pathways that influence UGRP2 activity. Other inhibitors like Apigenin, Nordihydroguaiaretic acid, Sulforaphane, and Zileuton also contribute to the regulation of UGRP2 through various pathways, including JAK/STAT signalling, lipoxygenase inhibition, Nrf2 pathway activation, and 5-lipoxygenase blocking, all of which affect the inflammatory mediators and responses where UGRP2 is active.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits UGRP2 by modulating the activity of protein tyrosine kinases, which are involved in the signaling pathways that regulate UGRP2 activity in the context of cellular differentiation and immune response. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can inhibit UGRP2 by its antioxidant action and regulation of signaling pathways such as PI3K/Akt, which are implicated in the regulation of UGRP2, particularly in inflammatory and immune contexts. | ||||||
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
Ebselen inhibits UGRP2 by mimicking glutathione peroxidase activity, reducing oxidative stress, and modulating redox-sensitive pathways that govern the functional expression of UGRP2 in airway inflammation and immunity. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin can inhibit UGRP2 by suppressing cyclooxygenase enzymes which are part of the inflammatory pathway, where UGRP2 has a role. By inhibiting COX, indomethacin indirectly reduces UGRP2 activity associated with pro-inflammatory signaling. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-acetylcysteine can inhibit UGRP2 function by providing antioxidant support and thereby modulating the redox state and oxidative stress-related pathways that influence UGRP2 activity. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin inhibits UGRP2 by affecting the Janus kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway, which plays a role in the signaling that regulates UGRP2 activity in immune response modulation. | ||||||
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
Nordihydroguaiaretic acid inhibits UGRP2 by acting as a lipoxygenase inhibitor, thereby affecting the arachidonic acid pathway and inflammatory mediators that are involved in the regulation of UGRP2 activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can inhibit UGRP2 by activating the Nrf2 pathway, which influences the inflammatory response in which UGRP2 is implicated. By modulating this pathway, sulforaphane indirectly affects UGRP2 activity related to oxidative stress response. | ||||||
Zileuton | 111406-87-2 | sc-204417 sc-204417A sc-204417B sc-204417C | 10 mg 50 mg 1 g 75 g | $84.00 $307.00 $369.00 $1254.00 | 8 | |
Zileuton inhibits UGRP2 by blocking 5-lipoxygenase, leading to a decrease in leukotriene production which is part of the inflammatory response where UGRP2 is active. By targeting this enzyme, zileuton can reduce the functional influence of UGRP2. | ||||||